Analyst Consensus ?
ConsensusBuy28 ratings
Bullish1864.3%
Neutral1035.7%
Bearish00.0%
2 unmapped firm ratings excluded from the percentages.
Teradyne, Inc. · TER · FY2025 Q1 · Calendar Q2 2025
Teradyne: AI test momentum offsets tariff and memory uncertainty
The supplied analysis supports a cautiously constructive view of Teradyne’s growth drivers: AI accelerator testing, HBM4, silicon photonics, and robotics automation. The thesis is not yet conclusive because tariff-related order pushouts, memory digestion, robotics profitability, and limited forward visibility could offset that momentum.
Reported Before market openNASDAQTechnology
$59.45B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $0.61
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $680.5M
Revenue surprise
—
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-0.4%
Event window
SPY move
+0.0%
Same window
Abnormal move
-0.4%
Stock minus SPY
Volume
1.2×
Versus trailing sessions
Subsequent drift
+6.4%
Up to 20 sessions
TERSPY benchmark
Ask FN2 about TER FY2025 Q1
Transcript, numbers and history already loaded
What drove TER's -0.4% move after FY2025 Q1 earnings?What changed in TER's guidance and outlook in FY2025 Q1?Give me the bull and bear case for TER after FY2025 Q1 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior-quarter analysis, the focus shifted from a broad AI and memory recovery story toward specific execution markers: an HBM4 wafer-level test win, Titan-HP ramp, a large robotics order, and the planned Quantifi Photonics acquisition. At the same time, tariff-driven order pushouts and uncertainty beyond Q2 became more prominent concerns.
Guidance delta
Maintained; the supplied analysis says management maintained its outlook while visibility beyond Q2 remained limited.
Key takeaways
- The supplied analysis describes Q1 revenue at the high end of guidance and non-GAAP EPS above expectations.
- AI accelerator system testing and an HBM4 wafer-level win are identified as growth signals.
- Tariff-related pushouts in automotive and industrial markets add demand uncertainty.
- Robotics showed a record order, while restructuring and the Quantifi Photonics acquisition remain execution items.
Management priorities
- Ramp Titan-HP system testing for AI accelerators
- Close the Quantifi Photonics acquisition and expand silicon-photonics testing
- Deploy robotics with Analog Devices in semiconductor fabs
- Invest in strategic growth while managing operating leverage
Follow TER with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$370.67Current
$116Low
$270.42Average
$550High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 14, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Baird | Neutral | Outperform | Downgrade | Aug 21, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 30, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 30, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jul 29, 2026 |
| UBS | Buy | Buy | Maintain | Jul 20, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Jul 6, 2026 |
| Susquehanna | Positive | Positive | Maintain | Jun 30, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jun 23, 2026 |
| JP Morgan | Overweight | Neutral | Upgrade | Apr 30, 2026 |
| Citigroup | Buy | Buy | Maintain | Apr 30, 2026 |
| Stifel | Buy | Buy | Maintain | Apr 28, 2026 |
| Keybanc | Overweight | Downgrade | Apr 17, 2025 | |
| Northland Capital Markets | Outperform | Outperform | Maintain | Jan 31, 2025 |
| Craig-Hallum | Hold | Hold | Maintain | Oct 25, 2024 |
| TD Cowen | Outperform | Outperform | Maintain | Oct 27, 2023 |
| Loop Capital | Hold | Hold | Maintain | May 1, 2023 |
| Deutsche Bank | Buy | Buy | Maintain | Apr 28, 2023 |
| Piper Sandler | Neutral | Neutral | Maintain | Apr 11, 2023 |
| Jefferies | Buy | Buy | Maintain | Jan 27, 2023 |
| DA Davidson | Buy | Buy | Maintain | Jul 27, 2022 |
| Rosenblatt | Buy | Buy | Maintain | Apr 28, 2022 |
| Credit Suisse | Neutral | Neutral | Maintain | Jan 28, 2022 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Oct 28, 2021 |
| CFRA | Hold | Hold | Maintain | Apr 22, 2020 |
| Citi | Buy | Buy | Maintain | Oct 25, 2019 |
| Stifel Nicolaus | Hold | Hold | Maintain | Oct 24, 2019 |
| Bank of America | Neutral | Buy | Downgrade | Nov 20, 2018 |
| Pacific Crest | Overweight | Downgrade | Oct 29, 2015 | |
| Sidoti & Co. | Buy | Buy | Maintain | Sep 23, 2015 |
| ISI Group | Neutral | Buy | Downgrade | Oct 3, 2014 |
Named analyst price targets
Upside is calculated against the persisted current price $370.67. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Analyst unavailable | $397 | $361.79 | +7.1% | Jul 30, 2026 |
| Robert W. Baird | Quinn Fredrickson | $420 | $359.71 | +13.3% | Jul 30, 2026 |
| Evercore ISI | Vedvati Shrotre | $420 | $357.42 | +13.3% | Jul 30, 2026 |
| Goldman Sachs | Analyst unavailable | $465 | $320.65 | +25.4% | Jul 28, 2026 |
| UBS | Timothy Arcuri | $500 | $340.06 | +34.9% | Jul 20, 2026 |
| Susquehanna | Analyst unavailable | $550 | $463.21 | +48.4% | Jun 30, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $550 | $436.86 | +48.4% | Jun 29, 2026 |
| Robert W. Baird | Analyst unavailable | $446 | $457 | +20.3% | Jun 23, 2026 |
| Morgan Stanley | Shane Brett | $387 | $351.03 | +4.4% | Apr 30, 2026 |
| Evercore ISI | Vedvati Shrotre | $370 | $345.56 | -0.2% | Apr 30, 2026 |
| Goldman Sachs | Analyst unavailable | $350 | $348.74 | -5.6% | Apr 30, 2026 |
| Robert W. Baird | Analyst unavailable | $350 | $306.33 | -5.6% | Apr 30, 2026 |
| Stifel Nicolaus | Brian Chin | $390 | $402 | +5.2% | Apr 28, 2026 |
| Evercore ISI | Analyst unavailable | $430 | $401.98 | +16.0% | Apr 27, 2026 |
| UBS | Analyst unavailable | $440 | $375.21 | +18.7% | Apr 21, 2026 |
| Susquehanna | Analyst unavailable | $415 | $364.21 | +12.0% | Apr 9, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $400 | $364.21 | +7.9% | Apr 9, 2026 |
| Morgan Stanley | Shane Brett | $306 | $318.09 | -17.4% | Feb 11, 2026 |
| Northland Securities | Gus Richard | $270 | $281.29 | -27.2% | Feb 4, 2026 |
| Stifel Nicolaus | Brian Chin | $325 | $280.38 | -12.3% | Feb 4, 2026 |
| Susquehanna | Analyst unavailable | $335 | $279.6 | -9.6% | Feb 4, 2026 |
| Robert W. Baird | Analyst unavailable | $305 | $282.98 | -17.7% | Feb 4, 2026 |
| Goldman Sachs | Analyst unavailable | $300 | $282.98 | -19.1% | Feb 3, 2026 |
| Morgan Stanley | Analyst unavailable | $288 | $282.98 | -22.3% | Feb 3, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $270 | $278.68 | -27.2% | Feb 3, 2026 |
| Evercore ISI | Analyst unavailable | $280 | $246.76 | -24.5% | Feb 2, 2026 |
| RBC Capital | Analyst unavailable | $270 | $252.9 | -27.2% | Feb 2, 2026 |
| Stifel Nicolaus | Analyst unavailable | $280 | $251.87 | -24.5% | Jan 30, 2026 |
| UBS | Analyst unavailable | $275 | $234.49 | -25.8% | Jan 26, 2026 |
| Stifel Nicolaus | Analyst unavailable | $270 | $226.08 | -27.2% | Jan 14, 2026 |
| Susquehanna | Analyst unavailable | $275 | $217.26 | -25.8% | Jan 12, 2026 |
| Vertical Research | Robert Jamieson | $220 | $218.05 | -40.6% | Jan 9, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $240 | $190.54 | -35.3% | Dec 16, 2025 |
| Goldman Sachs | James Schneider | $230 | $193.4 | -38.0% | Dec 15, 2025 |
| Stifel Nicolaus | Analyst unavailable | $225 | $179.63 | -39.3% | Dec 2, 2025 |
| Robert W. Baird | Richard Eastman | $195 | $184.17 | -47.4% | Oct 31, 2025 |
| UBS | Timothy Arcuri | $200 | $174.76 | -46.0% | Oct 30, 2025 |
| Susquehanna | Brian Chin | $215 | $174.76 | -42.0% | Oct 30, 2025 |
| Goldman Sachs | Analyst unavailable | $148 | $174.61 | -60.1% | Oct 30, 2025 |
| Northland Securities | Gus Richard | $186 | $173.94 | -49.8% | Oct 30, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $180 | $173.25 | -51.4% | Oct 29, 2025 |
| Industrial Alliance Securities | Analyst unavailable | $175 | $146.02 | -52.8% | Oct 28, 2025 |
| UBS | Analyst unavailable | $165 | $138.16 | -55.5% | Oct 20, 2025 |
| Morgan Stanley | Shane Brett | $136 | $139.13 | -63.3% | Oct 14, 2025 |
| Stifel Nicolaus | Analyst unavailable | $119 | $132.08 | -67.9% | Oct 13, 2025 |
| Northland Securities | Gus Richard | $161 | $141.17 | -56.6% | Oct 7, 2025 |
| Susquehanna | Mehdi Hosseini | $200 | $119.85 | -46.0% | Sep 22, 2025 |
| Goldman Sachs | Analyst unavailable | $85 | $107.65 | -77.1% | Jul 30, 2025 |
| Morgan Stanley | Analyst unavailable | $100 | $107.65 | -73.0% | Jul 30, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $105 | $90.39 | -71.7% | Jun 24, 2025 |
| Morgan Stanley | Analyst unavailable | $81 | $86.74 | -78.1% | Mar 14, 2025 |
| UBS | Timothy Arcuri | $130 | $87.16 | -64.9% | Mar 12, 2025 |
| Stifel Nicolaus | Brian Chin | $110 | $87.07 | -70.3% | Mar 12, 2025 |
| Vertical Research | Analyst unavailable | $135 | $108.54 | -63.6% | Mar 7, 2025 |
| Susquehanna | Mehdi Hosseini | $165 | $135.88 | -55.5% | Jan 22, 2025 |
| Robert W. Baird | Richard Eastman | $140 | $127.94 | -62.2% | Jul 29, 2024 |
| Citigroup | Atif Malik | $162 | $125.23 | -56.3% | Jul 26, 2024 |
| Craig-Hallum | Christian Schwab | $124 | $125.69 | -66.5% | Jul 26, 2024 |
| Susquehanna | Mehdi Hosseini | $145 | $124.34 | -60.9% | Jul 26, 2024 |
| Northland Securities | Gus Richard | $126 | $125 | -66.0% | Jul 26, 2024 |
| Stifel Nicolaus | Brian Chin | $140 | $124.34 | -62.2% | Jul 25, 2024 |
| Northland Securities | Gus Richard | $136 | $151.45 | -63.3% | Jul 18, 2024 |
| KeyBanc | Steve Barger | $180 | $154.8 | -51.4% | Jul 12, 2024 |
| UBS | Timothy Arcuri | $170 | $144.74 | -54.1% | Jun 18, 2024 |
| KeyBanc | Steve Barger | $149 | $139.51 | -59.8% | May 21, 2024 |
| Goldman Sachs | Toshiya Hari | $161 | $131.91 | -56.6% | May 20, 2024 |
| Morgan Stanley | Joseph Moore | $116 | $108.33 | -68.7% | Apr 8, 2024 |
| Citigroup | Analyst unavailable | $125 | $107.99 | -66.3% | Feb 6, 2023 |
| Goldman Sachs | Toshiya Hari | $106 | $96.08 | -71.4% | Jul 27, 2022 |
| Goldman Sachs | Toshiya Hari | $149 | $106.88 | -59.8% | Mar 12, 2022 |
| Craig-Hallum | Christian Schwab | $138 | $112.12 | -62.8% | Jan 30, 2022 |
| Robert W. Baird | Robert Mason CFA | $142 | $112.02 | -61.7% | Jan 28, 2022 |
| Rosenblatt Securities | Kevin Garrigan | $165 | $111.14 | -55.5% | Jan 27, 2022 |
| Susquehanna | Mehdi Hosseini | $150 | $111.14 | -59.5% | Jan 27, 2022 |
| Deutsche Bank | Sidney Ho | $120 | $111.14 | -67.6% | Jan 27, 2022 |
| Loop Capital Markets | Scott Graham | $202 | $158.1 | -45.5% | Jan 13, 2022 |
| Bank of America Securities | Vivek Arya | $205 | $156.46 | -44.7% | Jan 10, 2022 |
| Cowen & Co. | Krish Sankar | $150 | $136.79 | -59.5% | Oct 28, 2021 |
| D.A. Davidson | Thomas Diffely | $140 | $111.25 | -62.2% | Oct 7, 2021 |
| Wolfe Research | Blake Gendron | $158 | $131.98 | -57.4% | Apr 28, 2021 |
Track every rating change on TER the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationTeradyne, Inc., established in 1960 and headquartered in North Reading, Massachusetts, is a global leader specializing in the creation, production, sale, and maintenance of automated testing solutions. The company's operations are categorized into four principal divisions: 1. Semiconductor Test: This segment delivers solutions for testing microchips at both the wafer and finished device package stages. These capabilities serve a wide array of sectors, including automotive, industrial, telecommunications, consumer electronics, mobile devices, cloud computing, and gaming. Notable offerings include the FLEX test platform, the J750 system for high-volume semiconductor testing, the Magnum platform specialized for memory components like flash and DRAM, and the ETS platform, which caters to the analog/mixed-signal markets for chip makers and outsourced assembly/test providers.…
Historical context
All TER earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| ACN Accenture plc | FY2026 Q4 · Calendar Q4 2026 | +3.5% | +15.8% | Accenture: AI demand supports strong Q4, while pricing and geopolitics remain risks |
| JBL Jabil Inc. | FY2026 Q4 · Calendar Q3 2026 | +8.1% | -10.0% | Jabil enters FY2027 with AI-led growth and capacity risks |
| MU Micron Technology, Inc. | FY2026 Q4 · Calendar Q3 2026 | +5.4% | +0.0% | Micron: Strong AI Memory Demand, Higher Capex, and HBM4E Ahead |
| SNX TD Synnex Corp | FY2026 Q3 · Calendar Q3 2026 | +20.9% | -9.9% | TD SYNNEX: AI-led growth accelerates, but mix and cash flow matter |
| ADBE Adobe Inc. | FY2026 Q3 · Calendar Q3 2026 | +0.8% | +1.4% | Adobe raises FY26 outlook as AI strategy broadens |
| ORCL Oracle Corporation | FY2027 Q1 · Calendar Q3 2026 | +10.3% | -1.7% | Oracle raises FY27 outlook as AI demand accelerates cloud growth |
Latest beats and misses
Who reports nextBeat on EPS
Missed on EPS
Get the TER recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-04-14T00:04:42.211827+00:00
- Polygon adjusted daily market bars · 2026-10-14T12:30:43.456988+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-14T12:30:43.454248+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-14. For educational purposes only; not investment advice.